RIGEL PHARMACEUTICALS INC financial data

Symbol
RIGL on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 216% % 32%
Quick Ratio 11% % 6.1%
Debt-to-equity 256% %
Return On Equity 205% %
Return On Assets 57% % 1792%
Operating Margin 42% % 599%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18,151,344 shares 3%
Common Stock, Shares, Outstanding 17,710,216 shares 1.3%
Entity Public Float $143,100,000 USD -36%
Common Stock, Value, Issued $18,000 USD 5.9%
Weighted Average Number of Shares Outstanding, Basic 18,038,000 shares 2.5%
Weighted Average Number of Shares Outstanding, Diluted 19,156,000 shares 8.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $282,076,000 USD 79%
Costs and Expenses $163,125,000 USD 10%
Operating Income (Loss) $118,951,000 USD 1152%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $114,335,000 USD 122%
Income Tax Expense (Benefit) $1,035,000 USD
Net Income (Loss) Attributable to Parent $113,300,000 USD 2819%
Earnings Per Share, Basic 6.33 USD/shares 118%
Earnings Per Share, Diluted 6.19 USD/shares 109%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $48,534,000 USD -6.1%
Cash, Cash Equivalents, and Short-term Investments $137,200,000 USD 124%
Accounts Receivable, after Allowance for Credit Loss, Current $45,925,000 USD 50%
Inventory, Net $13,303,000 USD 178%
Other Assets, Current $5,863,000 USD
Assets, Current $214,927,000 USD 102%
Property, Plant and Equipment, Net $54,000 USD -45%
Operating Lease, Right-of-Use Asset $1,050,000 USD 159%
Other Assets, Noncurrent $1,167,000 USD -75%
Assets $242,534,000 USD 74%
Accounts Payable, Current $3,846,000 USD 0.81%
Employee-related Liabilities, Current $10,065,000 USD 27%
Contract with Customer, Liability, Current $1,355,000 USD 0%
Liabilities, Current $94,400,000 USD 74%
Operating Lease, Liability, Noncurrent $556,000 USD
Other Liabilities, Noncurrent $39,981,000 USD -0%
Liabilities $124,925,000 USD -19%
Accumulated Other Comprehensive Income (Loss), Net of Tax $96,000 USD 773%
Retained Earnings (Accumulated Deficit) $1,291,106,000 USD 8.1%
Stockholders' Equity Attributable to Parent $117,609,000 USD
Liabilities and Equity $242,534,000 USD 74%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $893,000 USD 82%
Net Cash Provided by (Used in) Financing Activities $484,000 USD
Net Cash Provided by (Used in) Investing Activities $10,552,000 USD -3471%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 17,710,216 shares 1.3%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $48,591,000 USD -6%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,653,000 USD -1.8%
Deferred Tax Assets, Valuation Allowance $329,234,000 USD -2.8%
Deferred Tax Assets, Gross $329,234,000 USD -2.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $113,385,000 USD 2802%
Lessee, Operating Lease, Liability, to be Paid $1,271,000 USD 160%
Property, Plant and Equipment, Gross $353,000 USD -81%
Operating Lease, Liability, Current $594,000 USD 27%
Lessee, Operating Lease, Liability, to be Paid, Year Two $409,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $692,000 USD 130%
Deferred Tax Assets, Operating Loss Carryforwards $222,744,000 USD -3.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $8,780,000 USD 1.2%
Operating Lease, Payments $16,000 USD -98%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $2,300,000 USD 28%
Depreciation, Depletion and Amortization $604,000 USD 51%
Share-based Payment Arrangement, Expense $12,050,000 USD -1.5%
Interest Expense $7,576,000 USD -3.7%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%